FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

March 7, 2022

Posted in In the NewsTagged #fdaapprovals, FDA, Research

Teliso-V granted FDA Breakthrough Designation for NSCLC

January 11, 2022

Posted in In the NewsTagged #fdaapprovals, FDA

2021 FDA approvals for lung cancer treatment

January 4, 2022

Posted in In the NewsTagged #fdaapprovals, #inthenews, FDA

FDA approves atezolizumab for stage II to IIIA lung cancer

October 15, 2021

Posted in In the NewsTagged #fdaapprovals, #inthenews, FDA

FDA approves mobocertinib for EGFR exon 20 insertion+ NSCLC

September 16, 2021

Posted in In the News, ResearchTagged #fdaapprovals, EGFR, FDA

Together Separately: 2020 FDA approvals

June 14, 2020

Posted in EducationTagged #fdaapprovals, FDA, togetherseparately

Approval of Keytruda Every Six Weeks a ‘Welcome Change’ for Patients With Cancer

May 31, 2020

Posted in In the News, ResearchTagged #fdaapprovals, FDA

FDA announcements speak to urgency of improving lung cancer treatment

May 12, 2020

Posted in In the News, ResearchTagged #fdaapprovals, FDA

New targeted therapy approved

August 16, 2019

Posted in In the News, ResearchTagged #fdaapprovals, FDA

FDA approves pembrolizumab for second or third-line treatment of metastatic small cell lung cancer

July 2, 2019

Posted in In the News, SCLCTagged #fdaapprovals, FDA, SCLC